cas 2497590-06-2|| where to buy (5S,8S,10aR)-3-acetyl-5-(tert-butoxycarbonylamino)-6-oxo-1,2,4,5,8,9,10,10a-octahydropyrrolo[1,2-a][1,5]diazocine-8-carboxylic acid

Nombre del producto:(5S,8S,10aR)-3-acetyl-5-(tert-butoxycarbonylamino)-6-oxo-1,2,4,5,8,9,10,10a-octahydropyrrolo[1,2-a][1,5]diazocine-8-carboxylic acid

IUPAC Name:(5S,8S,10aR)-3-acetyl-5-{[(tert-butoxy)carbonyl]amino}-6-oxo-decahydropyrrolo[1,2-a][1,5]diazocine-8-carboxylic acid

: CAS：2497590-06-2; Fórmula molecular：C17H27N3O6; Pureza：95%+

: Número de catálogo：CM1018630; Peso molecular：369.42

Unidad de embalaje	Stock disponible	Precio($)
CM1018630-250mg	in stock	ŴɅƱ
CM1018630-500mg	in stock	ǧƱƀ
CM1018630-1g	in stock	ƱƻȬ
CM1018630-5g	1-2 Weeks	ȁƙƀȬ
CM1018630-10g	1-2 Weeks	ɅŴǧȬ

Consulta: sales@chemenu.com

Sólo para uso en I+D..

Formulario de consulta

Nombre químico

Número CAS

Cantidad*

Especificaciones requeridas*
(% de ensayo, grado de material, etc.)

Nombre de contacto*

Correo electrónico de contacto*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 2497590-06-2 regularly via the above email.

Notas adicionales

Verification code*

refresh

Detalles del producto

: Núm. De CAS :2497590-06-2; Fórmula molecular:C17H27N3O6; Punto de fusión:-; Código de sonrisas:CC(=O)N1CC[C@H]2CC[C@@H](C(=O)O)N2C(=O)[C@@H](NC(=O)OC(C)(C)C)C1; Densidad:

: Número de catálogo:CM1018630; Peso molecular:369.42; Punto de ebullición:; Nº Mdl:; Almacenamiento:

Category Infos

: Pyrrolidines; Pyrrolidine, also known as tetrahydropyrrole, is a saturated five-membered heterocyclic ring, which is miscible with water. Pyrrolidine exists in many alkaloids and drug molecules, such as kappa opioids, antagonists of dopamine D4 receptors, and HIV reverse transcriptase inhibitors.

Column Infos

: KT-333; Kymera shared new clinical data from its ongoing KT-333 Phase 1 trial. KT-333, a first-in-class, potent, highly selective, heterobifunctional small molecule degrader of STAT3, demonstrated antitumor responses in hematological malignancies with high unmet need, including relapsed/refractory classic Hodgkin’s lymphoma (cHL), cutaneous T-cell lymphoma (CTCL), and NK-cell lymphoma, at doses that were well-tolerated.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.

Formulario de consulta

Detalles del producto

Category Infos

Column Infos

Related Products